WorldFirst's Enhanced Bank Partnerships and AI Tools Fuel 300% Transaction Growth in Emerging Markets
30.9.2025 14:48:00 CEST | Business Wire | Press release
Partnering with 30+ financial institutions globally, WorldFirst is making cross-border payments faster, easier, and more secure for businesses, driving a 300% transaction volume growth in emerging markets in H1 2025.By leveraging AI-driven tools for risk management and customer service, WorldFirst streamlines compliance and user experience to reduce regulatory frictions, unlocking growth for both financial partners and itself.WorldFirst has expanded its global footprint with new offices in Kuala Lumpur, Mexico, the UAE, and Saudi Arabia, strengthening local support capabilities across key growth regions.
WorldFirst, an all-in-one digital cross-border payment and treasury account service for global businesses, announced a 300% surge in emerging markets transaction volume during the first half of 2025. The growth figures were disclosed during WorldFirst's recent Financial Partners Day in London, which was attended by more than 60 representatives from over 30 financial institutions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250930587669/en/

WorldFirst and its financial partners came together to discuss how to advance collaboration to better serve SMEs at the WorldFirst Financial Partners Day in London.
A key goal of the Eurosystem’s retail payments strategy is to make it easier for businesses in Europe to send and receive payments to and from other countries. Against this backdrop, the event discussed how to leverage bank-fintech collaboration—through interoperability, SME-focused solutions, and digital innovation—to build a more resilient and inclusive financial ecosystem.
Simplifying Global Payments for Growing Businesses
Coco XU, founder of London-based pet supply brand Cococat, saw her eco-friendly cat litter soar into Amazon's top 100 within a year. "As a new brand with global ambition, our biggest challenge was managing multi-currency cash flow and securing efficient fund transfers to the UK," she said.
The turning point came when Cococat discovered WorldFirst. By leveraging WorldFirst’s account service, Cococat reduced transaction costs by 20% compared to traditional methods while cutting settlement time from 5-7 days to near real-time.
The story exemplifies the broader industry transformation. Over 1.2 million merchants worldwide, including Cococat, are using WorldFirst's bank-supported solutions featuring global coverage, secure transactions and operational efficiency. Key offerings include:
- World Account- A one-stop account for global payments, collections, FX conversion, and treasury management. Merchants can apply online in minutes to pay in 100+ currencies and collect in 20+ currencies to 200+ countries and regions.
- World Card- The virtual card solution empowers SMEs to streamline secure domestic and cross-border payments with greater financial control. The solution also plans to introduce credit access in the future and has scheduled a full-scale rollout in Europe this year.
- Value-added services- Competitive wholesale FX rates and forward contracts help SMEs reduce costs and hedge against currency risk, with a clear pathway to future advanced cash management solutions.
"The power of fintech-bank collaboration lies in building a more robust and inclusive financial ecosystem," noted Clara SHI, CEO of WorldFirst. "This synergy enables us to deliver solutions with global coverage, efficiency, and security to SMEs engaged in cross-border commerce. In turn, it provides our financial partners with a strategic gateway to the vibrant—and often hard-to-reach—SME economy."
WorldFirst’s banking network includes eight global systemically important banks, such as J.P. Morgan, Standard Chartered, Barclays, HSBC, Citibank and others. In Europe, BNP Paribas stands as one of its key strategic partners.
Pierre Fersztand, Global Head of Cash Management, Trade Solutions & Factoring at BNP Paribas, commented on the partnership: "Today’s clients expect seamless digital experiences supported by the stability of a global bank. Our collaboration with WorldFirst ensures we remain at the forefront of providing innovative trade finance and cash management services that drive growth and financial inclusion."
What’s next? Extending the technology and innovation to the industry
Banks and fintechs are making significant technological strides to bridge the gap between the needs of the global economy and the capabilities of today's cross-border payment systems. As part of this effort, WorldFirst is launching a series of AI-driven initiatives to enhance security, compliance, and user experience:
AI-driven risk management- WorldFirst enhances its fraud detection capabilities by integrating advanced AI and machine learning algorithms. This enables real-time transaction screening, maintains a sub-0.01% fraud rate, and streamlines compliance processes.
AI-Guided Cross-Border Support- WorldFirst’s intelligent assistant Anthea, provides 24/7 multilingual support—helping sellers overcome cross-cultural barriers, language gaps, and local payment preferences.
"At WorldFirst, we see AI as the core driver for the next generation of cross-border trade," highlighted Clara. "Our focus is shifting from merely leveraging AI for risk defense to actively deploying it to empower businesses. By simplifying technical complexity, we are democratizing access to the global economy and turning cross-border payments into a streamlined experience for every business."
Mahesh Kini, Global Head of Cash Management, Standard Chartered, said: "We are pleased to see the increased positive impact that our partnership with WorldFirst is making on its clients and the broader ecosystem. This is in line with our efforts to offer seamless and secure last mile digital payment and FX solutions that enable these companies to scale their operations."
Complementing its digital capabilities, WorldFirst is also expanding its physical presence with new offices in Kuala Lumpur, Mexico, the UAE, and Saudi Arabia—strengthening its local support network across key markets.
This approach resonates deeply with clients. As the founder of Cococat Coco Xu noted: "Another key deciding factor was WorldFirst’s physical presence. Knowing they have an office here in London is incredibly reassuring. Whenever we have a question, we can talk to a real person who understands our local context. It truly feels like a partnership."
About WorldFirst
WorldFirst offers cross-border payments and treasury services through its global business account, empowering growth for SMEs in e-commerce, trade, and the broad platform economy. WorldFirst simplifies key financial operations, including international payments, collections, currency conversions, and treasury management, all in a one-stop account. Leveraging the technological strengths, WorldFirst delivers industry-leading transaction security and reliability. WorldFirst has supported over 1.2 million customers, enabling payments in 100+ currencies across more than 210 countries and regions. Learn more about WorldFirst at https://www.worldfirst.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250930587669/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom